LASE vs. CRBP

Last updated Aug 1, 2026

LASE (Laser Photonics Corporation) and CRBP (Corbus Pharmaceuticals Holdings, Inc.) are both stocks. LASE operates in Specialty Industrial Machinery (Industrials), while CRBP operates in Biotechnology (Healthcare). Over the past 3 years, LASE returned -28.58%/yr vs 7.40%/yr for CRBP. Their 0.07 correlation means their historical movements had little consistent relationship.

Performance

LASE vs. CRBP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Laser Photonics Corporation (LASE) and Corbus Pharmaceuticals Holdings, Inc. (CRBP). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LASE achieves a -60.32% return, which is significantly lower than CRBP's 10.20% return.

LASE

• 1D: 0.00%
• 1M: -30.00%
• 6M: -49.48%
• YTD: -60.32%
• 1Y: -63.43%
• 3Y*: -28.58%
• 5Y*: —
• 10Y*: —
• ALL TIME*: -34.63%

CRBP

• 1D: -0.88%
• 1M: -3.03%
• 6M: 8.46%
• YTD: 10.20%
• 1Y: -3.65%
• 3Y*: 7.40%
• 5Y*: -26.25%
• 10Y*: -20.07%
• ALL TIME*: -17.86%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
CRBP Corbus Pharmaceuticals Holdings, Inc.	$2.30M	$2.68M	$4.28M
LASE Laser Photonics Corporation	$5.58M	$4.08M	$36.75M

LASE vs. CRBP - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
LASE Laser Photonics Corporation	-60.32%	-57.27%	389.83%	-42.16%	-59.20%
CRBP Corbus Pharmaceuticals Holdings, Inc.	10.20%	-31.02%	95.36%	82.20%	-36.78%

Correlation

The correlation between LASE and CRBP is 0.12, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.12
Correlation (3Y) Balances recent behavior with more history.	0.08
Correlation (All Time) Calculated using the full available price history since Sep 30, 2022	0.07

Fundamentals

Market Cap LASE : $16.79M CRBP : $166.19M
EPS LASE : -$0.44 CRBP : -$5.72
Total Revenue (TTM) LASE : $7.14M CRBP : $0.00
Gross Profit (TTM) LASE : $2.22M CRBP : -$149.00K
EBITDA (TTM) LASE : -$8.37M CRBP : -$61.36M

Return for Risk

LASE vs. CRBP — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

LASE

LASE Risk / Return Rank: 37
LASE Sharpe Ratio Rank: 32
LASE Sortino Ratio Rank: 57
LASE Omega Ratio Rank: 56
LASE Calmar Ratio Rank: 17
LASE Martin Ratio Rank: 24

CRBP

CRBP Risk / Return Rank: 44
CRBP Sharpe Ratio Rank: 42
CRBP Sortino Ratio Rank: 46
CRBP Omega Ratio Rank: 48
CRBP Calmar Ratio Rank: 43
CRBP Martin Ratio Rank: 43

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

LASE vs. CRBP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Laser Photonics Corporation (LASE) and Corbus Pharmaceuticals Holdings, Inc. (CRBP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	LASE	CRBP	Difference
Sharpe ratio: Return per unit of total volatility	-0.28	-0.04	-0.24
Sortino ratio: Return per unit of downside risk	0.92	0.52	+0.41
Omega ratio: Gain probability vs. loss probability	1.11	1.07	+0.04
Calmar ratio: Return relative to maximum drawdown	-0.72	-0.05	-0.66
Martin ratio: Return relative to average drawdown	-0.96	-0.07	-0.89

LASE vs. CRBP - Sharpe Ratio Comparison

The current LASE Sharpe Ratio is -0.28, which is lower than the CRBP Sharpe Ratio of -0.04. The chart below compares the historical Sharpe Ratios of LASE and CRBP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

LASE vs. CRBP - Drawdown Comparison

The maximum LASE drawdown since its inception was -96.80%, roughly equal to the maximum CRBP drawdown of -99.31%. Use the drawdown chart below to compare losses from any high point for LASE and CRBP.

Drawdown Indicators

	LASE	CRBP	Difference
Max Drawdown Largest peak-to-trough decline	-96.80%	-99.31%	+2.51%
Max Drawdown (1Y) Largest decline over 1 year	-90.76%	-61.88%	-28.88%
Max Drawdown (3Y) Largest decline over 3 years	-96.80%	-92.01%	-4.79%
Max Drawdown (5Y) Largest decline over 5 years	—	-94.87%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-99.31%	—
Current Drawdown Current decline from peak	-94.79%	-97.11%	+2.32%
Average Drawdown Average peak-to-trough decline	-71.46%	-66.40%	-5.06%
Ulcer Index Depth and duration of drawdowns from previous peaks	67.55%	45.40%	+22.15%

Volatility

LASE vs. CRBP - Volatility Comparison

Laser Photonics Corporation (LASE) has a higher volatility of 34.45% compared to Corbus Pharmaceuticals Holdings, Inc. (CRBP) at 11.86%. This indicates that LASE's price experiences larger fluctuations and is considered to be riskier than CRBP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LASE	CRBP	Difference
Volatility (1M) Calculated over the trailing 1-month period	34.45%	11.86%	+22.59%
Volatility (6M) Calculated over the trailing 6-month period	149.96%	59.99%	+89.97%
Volatility (1Y) Calculated over the trailing 1-year period	234.89%	79.24%	+155.65%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	185.23%	159.05%	+26.18%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	185.23%	129.03%	+56.20%

Dividends

LASE vs. CRBP - Dividend Comparison

Neither LASE nor CRBP has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both LASE and CRBP in my portfolio?

LASE and CRBP have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, LASE or CRBP?

LASE has higher volatility (34.45%) compared to CRBP (11.86%). In terms of maximum drawdown, LASE dropped -96.80% vs CRBP's -99.31%.

Which has better risk-adjusted returns?

CRBP currently has the higher Sharpe Ratio (-0.04 vs -0.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.